Calcipotriene and corticosteroid combination therapy for vitiligo

Pediatric Dermatology

Volumn 21, Issue 4, 2004, Pages 495-498

  Travis, Lisa B ^a   Silverberg, Nanette B ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CORTICOSTEROID; HYDROCORTISONE; MOMETASONE FUROATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; EYELID; FACE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SIDE EFFECT; SKIN PIGMENTATION; TREATMENT FAILURE; TREATMENT OUTCOME; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CALCITRIOL; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; TREATMENT OUTCOME; VITILIGO;

EID: 3943073098     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0736-8046.2004.21418.x     Document Type: Article

References (25)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-666.
2. Lebwohl M. Topical application of calcipotriene and corticosteroids: combination regimens. J Am Acad Dermatol 1997;37(suppl):S55-S58.
3. Koo J. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review. J Am Acad Dermatol 1997;37(suppl):S59-S61.
4. Cunliffe WJ, Berth-Jones J, Claudy A, et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992;26:736-743.
5. Lebwohl M, Siskin S, Epinette W, et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared to either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996;35:268-269.
6. Choi YJ, Hann SK, Chang SN, Park WH. Infantile psoriasis: successful treatment with topical calcipotriol. Pediatr Dermatol 2000;17:242-244.
7. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001;145:476-479.
8. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br Med J 2001;145:472-475.
9. Yalcin B, Sahin S, Bukulmez G, et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol 2001;44:634-7.
10. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998;197:167-170.
11. Parsad D, Saini RDNB, Napal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999;16:317-320.
12. Kissmeyer A-M, Calverley MJ, Benderup L. Chemistry and pharmacology of calcipotriol. In: Kragballe K, ed. Vitamin D in dermatology. New York: Marcel Dekker 2000;169-183.
13. Bilke DD. Vitamin D: a calciotropic hormone regulating calcium-induced keratinocyte differentiation. J Am Acad Dermatol 1997;37(suppl):S42-S52.
14. Reichrath J, Muller SM, Kerber A, et al. Biological effects of topical calcipotriol (MC 903) treatment in psoriatic skin. J Am Acad Dermatol 1997;36:19-28.
15. Dam TN. Effect of vitamin D on Langerhans cells. In: Kragballe K, ed. Vitamin D in dermatology. New York: Marcel Dekker 2000;143-156.
16. Skov L, Baadsgaard O, Hansen ER. Modulation of immunocytes by vitamin D. In: Kragballe K, ed. Vitamin D in dermatology. New York: Marcel Dekker 2000;133-141.
17. Roitt I, Brostoff J, Male D. Immunology. London: Mosby International, 2001;67-69.
18. Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001;44:837-846.
19. Mason RS, Pryke AM, Ranson M, Thomas HB, Posen S. Human melanoma cells: functional modulation by calcipotropic hormones. J Invest Dermatol 1988;90:830-840.
20. Hosoi J, Abe E, Suda T, Kuroki T. Regulation of melanin synthesis of B 16 melanoma cells by 1α,25-dihydroxyvitamin D3 and retinoic acid. Cancer Res 1985;45:1474-1478.
21. Tomita Y, Torinuki W, Tagami H. Stimulation of human melanocytes by vitamin D3 possibly mediates skin pigmentation after sun exposure. J Invest Dermatol 1988;90:882-884.
22. Schallreuter KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996;228:11-13.
23. Schallreuter KU, Pittelkow MR. Defective calcium uptake in keratinocyte cell culture from vitiliginous skin. Arch Dermatol Res 1988;280:137-139.
24. Kokelji F, Lavaroni G, Perkan V, Plozzer C. Hyperpigmentation due to calcipotriol (MC 903) plus heliotherapy in psoriatic patients. Acta Derm Venereol (Stockh) 1995;75:307-309.
25. Glaser R, Rowert J, Mrowietz U. Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriatic patients. Br J Dermatol 1998;139:148-151.